Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The salivary proteins, mucins, and acquired enamel pellicle (AEP) components represent a diverse group of molecules that form the primary interface between the oral environment and tooth surfaces. The AEP is a thin, acellular film formed by the selective adsorption of salivary glycoproteins and phosphoproteins, such as statherin, cystatins, and proline-rich proteins, onto the hydroxyapatite surface of teeth (Siqueira et al., 2012, Journal of Dental Research) [1]. This structure acts as a semi-permeable barrier that regulates mineral homeostasis, promotes remineralization, and protects against acid-induced erosion (Hannig & Hannig, 2009, Monographs in Oral Science) [2]. Salivary mucins, specifically MUC5B and MUC7, play a vital role in lubricating oral tissues and aggregating bacteria to facilitate their clearance from the mouth (Frenkel & Ribbeck, 2015, Journal of Oral Microbiology) [3]. Dysregulation or deficiency in these components is linked to dental caries, periodontal disease, and xerostomia (Lendenmann et al., 2000, Advances in Dental Research) [4]. Pharmacological agents, including fluoride and antimicrobial rinses, interact with this protein layer to modify bacterial adhesion and enhance the protective properties of the tooth surface (Zero, 2006, BMC Oral Health) [5]. [1] Siqueira WL, et al. (2012) J Dent Res. [2] Hannig M, Hannig C. (2009) Monogr Oral Sci. [3] Frenkel ES, Ribbeck K. (2015) J Oral Microbiol. [4] Lendenmann U, et al. (2000) Adv Dent Res. [5] Zero DT. (2006) BMC Oral Health.
Modification of pellicle permeability, inhibition of bacterial biofilm formation, and enhancement of mineral deposition on the enamel surface.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salivary proteins, mucins, and acquired enamel pellicle components (AEP) (AEP).